🔎 Trials Near Me

Utama › Sindrom Down › Pennsylvania

Kajian klinikal Sindrom Down di Pennsylvania

6 kajian untuk Sindrom Down sedang mencari peserta di lokasi di Pennsylvania.

Bandar di Pennsylvania

Teks kajian rasmi (Bahasa Inggeris)

Down Syndrome Obstructive Sleep Apnea

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 2
Umur 5 hingga 18 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06043440

Endotype DIrected Treatment for OSA in Down Syndrome

  • Children's Hospital of Philadelphia, Philadelphia
Mengambil pesertaFasa 4
Umur 6 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07280468

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Geisinger Medical Center, Danville
  • Penn State Children's Hospital, Hershey
  • dan 3 lagi
Mengambil pesertaFasa 2
Umur 1 hingga 30 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT04546399

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Mengambil pesertaKajian pemerhatian
Umur 6 hingga 39 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT05702645

Collaboration for Down Syndrome Progress (CDP)

  • The Children's Hospital of Philadelphia, Philadelphia
  • The Children's Hospital of Philadelphia, Philadelphia
  • University of Pittsburgh, Pittsburgh
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 4 Jun 2026 · NCT07625579

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • University of Pittsburgh, Co-Enrolling through ABC-DS Only, Pittsburgh
Mengambil pesertaKajian pemerhatian
Umur 25 hingga 55 · Semua jantina · Dikemas kini 18 Mei 2026 · NCT04165109

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.